
OPKO Health OPK
€ 1.18
0.0%
Quartalsbericht 2025-Q2
hinzugefügt 31.07.2025
OPKO Health Langfristiger Schuldenstrom 2011-2026 | OPK
Langfristiger Schuldenstrom Jährlich OPKO Health
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12.6 M | 13 M | 11.6 M | 11.6 M | 9.03 M | 12 M | - | 11.9 M | 12 M | 11.5 M | 13.5 M | 12.6 M | - | 8.76 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 13.5 M | 8.76 M | 11.7 M |
Langfristiger Schuldenstrom anderer Aktien in der Diagnostik & Forschung
| Name | Langfristiger Schuldenstrom | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
2.18 M | - | -6.23 % | $ 30.6 M | ||
|
Brainsway Ltd.
BWAY
|
824 K | $ 22.95 | -0.61 % | $ 99.4 M | ||
|
Akumin
AKU
|
17.2 M | - | -17.87 % | $ 25.9 M | ||
|
Accelerate Diagnostics
AXDX
|
829 K | - | -61.36 % | $ 2.46 M | ||
|
Danaher Corporation
DHR
|
173 M | $ 237.39 | 1.0 % | $ 174 B | ||
|
DarioHealth Corp.
DRIO
|
111 K | $ 12.34 | -4.38 % | $ 350 M | ||
|
Biocept
BIOC
|
518 K | - | -13.05 % | $ 7.29 M | ||
|
DexCom
DXCM
|
21.1 M | $ 67.58 | -1.23 % | $ 26.1 B | ||
|
BioNano Genomics
BNGO
|
2.99 M | $ 1.59 | -0.94 % | $ 2.02 M | ||
|
Chembio Diagnostics
CEMI
|
915 K | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
264 K | - | - | $ 9.42 M | ||
|
Co-Diagnostics
CODX
|
838 K | $ 6.03 | -1.45 % | $ 177 M | ||
|
IQVIA Holdings
IQV
|
99 M | $ 244.83 | 0.69 % | $ 44.4 B | ||
|
Castle Biosciences
CSTL
|
1.66 M | $ 38.99 | -2.26 % | $ 1.08 B | ||
|
Global Cord Blood Corporation
CO
|
147 K | - | - | $ 399 M | ||
|
DermTech
DMTK
|
3.07 M | - | -11.32 % | $ 2.94 M | ||
|
Genetic Technologies Limited
GENE
|
264 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
21.5 M | - | 0.12 % | $ 80.1 M | ||
|
Natera
NTRA
|
7.64 M | $ 233.95 | -2.34 % | $ 23 B | ||
|
CareDx, Inc
CDNA
|
5.94 M | $ 17.16 | -0.38 % | $ 923 M | ||
|
Celcuity
CELC
|
172 K | $ 104.35 | -0.31 % | $ 4.12 B | ||
|
Enzo Biochem
ENZ
|
841 K | - | -8.98 % | $ 14.8 K | ||
|
Anixa Biosciences
ANIX
|
29 K | $ 3.38 | -1.17 % | $ 108 K | ||
|
Exact Sciences Corporation
EXAS
|
27.4 M | $ 102.12 | 0.33 % | $ 18.9 B | ||
|
Pacific Biosciences of California
PACB
|
9.59 M | $ 1.97 | -3.43 % | $ 500 M | ||
|
Fulgent Genetics
FLGT
|
1.44 M | $ 27.9 | 0.02 % | $ 844 M | ||
|
QIAGEN N.V.
QGEN
|
23.4 M | $ 48.36 | -0.19 % | $ 10.8 B | ||
|
RadNet
RDNT
|
56.6 M | $ 78.45 | 0.09 % | $ 5.73 B | ||
|
Guardant Health
GH
|
29.2 M | $ 108.76 | 0.02 % | $ 13.3 B | ||
|
Aspira Women's Health
AWH
|
77 K | - | -6.19 % | $ 10.5 M | ||
|
Heska Corporation
HSKA
|
2.94 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
475 K | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
79 M | $ 141.31 | -3.1 % | $ 22.5 B | ||
|
Charles River Laboratories International
CRL
|
54.2 M | $ 221.27 | 2.64 % | $ 11.4 B | ||
|
Thermo Fisher Scientific
TMO
|
261 M | $ 617.5 | 1.81 % | $ 236 B | ||
|
Twist Bioscience Corporation
TWST
|
13.8 M | $ 35.42 | 1.96 % | $ 2.12 B | ||
|
Quest Diagnostics Incorporated
DGX
|
173 M | $ 176.09 | -0.96 % | $ 19.5 B | ||
|
Biodesix
BDSX
|
719 K | $ 5.36 | -4.11 % | $ 695 M | ||
|
Laboratory Corporation of America Holdings
LH
|
185 M | $ 254.43 | -0.1 % | $ 21.3 B | ||
|
ICON Public Limited Company
ICLR
|
24.3 M | $ 184.65 | -1.9 % | $ 15.2 B | ||
|
IDEXX Laboratories
IDXX
|
21.5 M | $ 714.6 | 0.31 % | $ 58.9 B | ||
|
Lantheus Holdings
LNTH
|
1.87 M | $ 67.0 | -1.25 % | $ 4.64 B | ||
|
Biomerica
BMRA
|
358 K | $ 2.7 | -6.57 % | $ 6.2 M | ||
|
Bioventus
BVS
|
4.06 M | $ 7.86 | -1.75 % | $ 492 M |